Heterogeneous/JJ
expression/NN
of/IN
the/DT
lipocalin/NN
NGAL/NN
in/IN
primary/JJ
breast/NN
cancers/NNS
./.

We/PRP
have/VBP
previously/RB
shown/VBN
that/IN
neu/NN
oncogene-initiated/JJ
rat/NN
mammary/JJ
carcinomas/NNS
uniquely/RB
over-express/VBP
neu-related/JJ
lipocalin/NN
(/(
NRL/NN
)/)
,/,
a/DT
member/NN
of/IN
the/DT
calycin/NN
protein/NN
superfamily/NN
./.
=====
Here/RB
,/,
we/PRP
characterize/VBP
the/DT
putative/JJ
human/JJ
homolog/NN
of/IN
NRL/NN
,/,
neutrophil/NN
gelatinase-associated/JJ
lipocalin/NN
(/(
NGAL/NN
)/)
./.
=====
ngal/JJ
gene/NN
expression/NN
was/VBD
found/VBN
at/IN
moderate/JJ
levels/NNS
in/IN
only/RB
2/CD
of/IN
17/CD
human/JJ
tissues/NNS
examined/VBN
,/,
breast/NN
and/CC
lung/NN
./.
=====
When/WRB
breast/NN
cancers/NNS
were/VBD
examined/VBN
for/IN
NGAL/NN
mRNA/NN
and/CC
protein/NN
levels/NNS
,/,
they/PRP
were/VBD
found/VBN
to/TO
exhibit/VB
heterogeneous/JJ
expression/NN
./.
=====
NGAL/NN
levels/NNS
varied/VBD
in/IN
these/DT
tumors/NNS
from/IN
undetectable/JJ
to/TO
exceeding/VBG
those/DT
in/IN
normal/JJ
breast/NN
parenchyma/NN
./.
=====
Immuno-histochemical/JJ
analysis/NN
confirmed/VBD
the/DT
presence/NN
of/IN
NGAL/NN
within/IN
breast/NN
carcinoma/NN
cells/NNS
but/CC
detected/VBD
only/RB
low/JJ
levels/NNS
of/IN
this/DT
protein/NN
in/IN
normal/JJ
ductal/JJ
epithelium/NN
./.
=====
In/IN
contrast/NN
,/,
large/JJ
amounts/NNS
of/IN
the/DT
protein/NN
were/VBD
localized/JJ
to/TO
the/DT
lumen/NN
of/IN
normal/JJ
breast/NN
ducts/NNS
in/IN
the/DT
vicinity/NN
of/IN
NGAL-expressing/JJ
tumors/NNS
./.
=====
Interestingly/RB
,/,
unlike/IN
NRL/NN
in/IN
rat/NN
mammary/JJ
carcinomas/NNS
,/,
no/DT
significant/JJ
association/NN
between/IN
NGAL/NN
expression/NN
and/CC
HER-2/neu/NN
activation/NN
was/VBD
found/VBN
in/IN
human/JJ
breast/NN
tumors/NNS
./.
=====
In/IN
contrast/NN
,/,
a/DT
significant/JJ
correlation/NN
between/IN
NGAL/NN
expression/NN
in/IN
breast/NN
cancer/NN
was/VBD
found/VBN
with/IN
several/JJ
other/JJ
markers/NNS
of/IN
poor/JJ
prognosis/NN
,/,
including/VBG
estrogen/NN
and/CC
progesterone/NN
receptor-negative/JJ
status/NN
and/CC
high/JJ
proliferation/NN
(/(
S-phase/NN
fraction/NN
)/)
./.
=====
NGAL/NN
levels/NNS
were/VBD
stratified/VBN
as/IN
high/JJ
or/CC
low/JJ
in/IN
breast/NN
cancers/NNS
from/IN
a/DT
cohort/NN
of/IN
node-positive/JJ
patients/NNS
with/IN
known/JJ
outcome/NN
./.
=====
No/DT
significant/JJ
association/NN
between/IN
NGAL/NN
expression/NN
and/CC
disease-free/JJ
or/CC
overall/JJ
survival/NN
was/VBD
observed/VBN
./.